Table 1
System suitability results.
| Standard | Average | % RSD |
| Glimepiride | | | Retention time | 5.043 | 0.26 | Area | 14711933 | 0.13 | Resolution | 4.924 | | Theoretical plates | 7063 | | Asymmetry | 0.898 | |
| Pioglitazone | | | Retention time | 3.977 | 0.27 | Area | 11302936 | 0.1 | Resolution | 15.52 | | Theoretical plates | 6782 | | Asymmetry | 0.94 | |
| Metformin | | | Retention time | 1.342 | 0 | Area | 11142195 | 0.31 | Resolution | 0 | | Theoretical plates | 1347 | | Asymmetry | 1.17 | |
| Dosage form | | |
| Glimepiride | | | Retention time | 5.071 | 0.11 | Area | 14719434 | 0.1 | Resolution | 4.99 | | Theoretical plates | 7142.925 | | Asymmetry | 0.88 | |
| Pioglitazone | | | Retention time | 3.992 | 0 | Area | 11285309.5 | 0.11 | Resolution | 15.775 | | Theoretical plates | 6893.845 | | Asymmetry | 0.93 | |
| Metformin | | | Retention time | 1.342 | 0 | Area | 11109070.5 | 0.31 | Resolution | 0 | | Theoretical plates | 1396.245 | | Asymmetry | 1.205 | |
|
|